By G HossainPosted on July 29, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs CEO Rob Davis referred to the cost reduction program as a ‘reallocation’ rather than a cut, with the savings to be reinvested to support up to 20 new product launches. Merck Cuts $3B to Support Aggressive Launch Schedule, Late-Stage R&D Post navigation Novo Nordisk Names New Leader, Cuts 2025 Sales Guidance By 5%AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D